Charles River Laboratories International (CRL) Other Non-Current Liabilities (2009 - 2025)

Charles River Laboratories International's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $138.3 million for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities fell 29.15% year-over-year to $138.3 million; the TTM figure through Dec 2025 stood at $138.3 million (down 29.15% YoY), while the FY2025 annual figure was $138.3 million, down 29.15% from the prior year.
• Other Non-Current Liabilities for Q4 2025 stood at $138.3 million, down from $189.5 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $242.9 million in Q4 2021, with the low at $138.3 million in Q4 2025.
• The 5-year median for Other Non-Current Liabilities is $195.8 million (2024), against an average of $201.8 million.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities soared 37.19% in 2024, then fell 29.15% in 2025.
• Charles River Laboratories International's Other Non-Current Liabilities stood at $242.9 million in 2021, then retreated by 28.02% to $174.8 million in 2022, then climbed by 27.67% to $223.2 million in 2023, then dropped by 12.54% to $195.2 million in 2024, then decreased by 29.15% to $138.3 million in 2025.
• Business Quant data shows CRL's Other Non-Current Liabilities at $138.3 million in Q4 2025, $189.5 million in Q3 2025, and $185.2 million in Q2 2025.